- Home
- FIGS vs AMLX Comparison
FIGS vs AMLX Comparison
Compare FIGS & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIGS
- AMLX
- Stock Information
- Founded
- FIGS 2013
- AMLX 2014
- Country
- FIGS United States
- AMLX United States
- Employees
- FIGS N/A
- AMLX N/A
- Industry
- FIGS Apparel
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- FIGS Consumer Discretionary
- AMLX Health Care
- Exchange
- FIGS Nasdaq
- AMLX Nasdaq
- Market Cap
- FIGS 1.2B
- AMLX 1.3B
- IPO Year
- FIGS 2021
- AMLX 2022
- Fundamental
- Price
- FIGS $9.62
- AMLX $14.79
- Analyst Decision
- FIGS Hold
- AMLX Strong Buy
- Analyst Count
- FIGS 5
- AMLX 7
- Target Price
- FIGS $8.60
- AMLX $17.43
- AVG Volume (30 Days)
- FIGS 2.7M
- AMLX 1.5M
- Earning Date
- FIGS 11-06-2025
- AMLX 11-06-2025
- Dividend Yield
- FIGS N/A
- AMLX N/A
- EPS Growth
- FIGS 91.65
- AMLX N/A
- EPS
- FIGS 0.11
- AMLX N/A
- Revenue
- FIGS $581,034,000.00
- AMLX N/A
- Revenue This Year
- FIGS $4.73
- AMLX N/A
- Revenue Next Year
- FIGS $3.67
- AMLX N/A
- P/E Ratio
- FIGS $91.90
- AMLX N/A
- Revenue Growth
- FIGS 5.90
- AMLX N/A
- 52 Week Low
- FIGS $3.57
- AMLX $2.60
- 52 Week High
- FIGS $10.24
- AMLX $16.96
- Technical
- Relative Strength Index (RSI)
- FIGS 65.50
- AMLX 60.27
- Support Level
- FIGS $8.95
- AMLX $11.93
- Resistance Level
- FIGS $10.24
- AMLX $15.09
- Average True Range (ATR)
- FIGS 0.52
- AMLX 1.00
- MACD
- FIGS 0.04
- AMLX 0.14
- Stochastic Oscillator
- FIGS 77.66
- AMLX 89.70
About FIGS FIGS Inc.
FIGS Inc is a healthcare apparel company. The Company designs and sells scrubwear and non-scrubwear, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear and other apparel. The Company generates maximum revenue from United States. Sales are generated through the Company's digital platforms.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.